Nomura Holdings’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-56,800
Closed -$3.39M 1536
2022
Q4
$3.39M Sell
56,800
-10,800
-16% -$587K 0.01% 592
2022
Q3
$3.07M Buy
+67,600
New +$3.38M 0.01% 704
2022
Q2
Sell
-25,140
Closed -$1.43M 1903
2022
Q1
$1.43M Sell
25,140
-347,938
-93% -$18.2M ﹤0.01% 992
2021
Q4
$19.4M Buy
+373,078
New +$19.2M 0.05% 278
2019
Q3
Sell
-15,335
Closed -$763K 1237
2019
Q2
$763K Buy
+15,335
New +$744K ﹤0.01% 886
2017
Q4
Sell
-59,582
Closed -$2.2M 1553
2017
Q3
$2.2M Buy
+59,582
New +$2.12M ﹤0.01% 817

Other funds holding EHC

Nomura Holdings's EHC Position: Q1 2025 in Review

Nomura Holdings sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 13,368 shares — an estimated $1.23M sold.

Nomura Holdings first reported a position in EHC in Q2 2013 and held it in 15 quarters. The position peaked at $9.55M in Q1 2022. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Nomura Holdings reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Nomura Holdings sold 13,368 Encompass Health shares in Q1 2025, an estimated $1.23M.
  • Nomura Holdings first reported a position in Encompass Health in Q2 2013 and held it in 15 quarters.
  • Nomura Holdings's Encompass Health position peaked at $9.55M in Q1 2022.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.